Your email has been successfully added to our mailing list.

×
0 0.000148632580261669 -0.000445897740784797 -0.00341854934601671 -0.000297265160523128 0.00356718192627838 0.00564803804994048 0.00391795481569555
Stock impact report

Novo Nordisk A/S (NVO) [Yahoo! Finance Canada]

AstraZeneca PLC - American Depositary Shares (AZN) 
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm Check Earnings Report
US:NYSE Investor Relations: astrazeneca.com/investor-relations.html
Novo was first to market with Saxenda and then Wegovy, but Lilly has quickly closed the gap. Now, the company appears to be pulling ahead of its Danish rival to develop the next blockbuster weight-loss treatment. Lilly expects to submit orforglipron for weight management to regulators by the end of this year with the submission for type 2 diabetes anticipated to come in 2026, the company said in a statement. Weight-loss shots made by Novo and Lilly have been wildly popular, generating billions of dollars in sales. But drugs than can be taken by mouth, rather than injected, are considered the next frontier. It's lured companies like Pfizer and AstraZeneca Plc to try to develop their own weight-loss pills, with varying degrees of success. Recommended Stories Show less Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for AZN alerts
Opt-in for
AZN alerts

from News Quantified
Opt-in for
AZN alerts

from News Quantified